C4A.61

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds, which damages the skin cells. Immunosuppression, such as in people who have organ transplants or HIV/AIDS, increasing susceptibility. Older age, as MCC is more common in individuals over 50, with risk increasing with age. Fair skin that burns easily, which has less melanin to protect against UV damage. Presence of Merkel cell polyomavirus, a virus linked to many cases of MCC, though its exact role is still being studied.

Key Symptoms: Painless, firm, and rapidly growing skin nodules, often reddish or skin-colored. Lesions that may be shiny or have a smooth surface, with a possible bluish or violet hue. Lesions typically appear on sun-exposed areas like the limbs, including the shoulder area. Possible ulceration or bleeding in advanced cases. Sometimes, associated swelling or lymph node enlargement near the affected area.

Diagnosis Path: Diagnosis usually involves a physical examination of the skin lesion, followed by a biopsy to confirm the presence of cancer cells. Additional tests such as sentinel lymph node biopsy may be performed to assess whether the cancer has spread. Imaging studies like CT scans or PET scans could be utilized to determine the extent of disease spread. Early detection through prompt medical evaluation is crucial for effective management.

Treatment Protocols: Surgical excision to remove the tumor completely, often with wide margins to ensure all cancerous cells are eliminated. Radiation therapy, either as a primary treatment or post-surgery, to target residual cancer cells. Immunotherapy drugs that stimulate the body's immune system to fight the cancer, especially in advanced cases. Chemotherapy, though less commonly used, may be considered for metastatic or recurrent MCC. Follow-up care is essential, involving regular skin checks and imaging to monitor for recurrence or spread.